Results 101 to 110 of about 24,117,299 (286)

Low light image enhancement - GFT

open access: yes
This dataset contains MATLAB code used for enhancing low-light images based on the coefficients derived from the Sakaguchi-type functions subordinated to the Gegenbauer polynomial.
K, S (via Mendeley Data)   +1 more
core   +1 more source

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani   +9 more
wiley   +1 more source

Unsupervised Low-light Image Enhancement Model with Adaptive Noise Suppression and Detail Preservation [PDF]

open access: yesJisuanji kexue
The visual quality of images taken under low-light environment is usually low,due to many factors such as low lightness and imaging noise.Current low-light image enhancement methods have a common limitation that they only focus on improving lightness ...
GAO Ren, HAO Shijie, GUO Yanrong
doaj   +1 more source

Regulation of the lncRNA NEAT1 by p53‐ΔNp63 crosstalk modulates the DNA damage response and therapeutic efficacy in HNSCC

open access: yesMolecular Oncology, EarlyView.
In head and neck squamous cell carcinoma (HNSCC) p53 and p63 exert opposite roles on the transcription regulation of the lncRNA NEAT1. Under basal conditions, p53 levels are low and p63 represses NEAT1 expression. Upon genotoxic stress, p53 is rapidly induced, displacing p63 from the NEAT1 promoter leading to NEAT1 transcriptional activation and ...
Sara De Domenico   +5 more
wiley   +1 more source

SCAUNet: Step-Size-Consistent ADMM Unfolding Network for Low-Light Image Enhancement

open access: yesMathematics
Low-light image enhancement aims to restore visually pleasing normal-light images from degraded low-light observations. Most existing methods handle luminance variation from the enhancement perspective.
Xiaofang Li, Hongbiao Tian, Cui Fu
doaj   +1 more source

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim   +17 more
wiley   +1 more source

Low-illumination Object-Detection Algorithm Based on Image Adaptive Enhancement [PDF]

open access: yesJisuanji gongcheng
In the case of detection tasks in low-light environments, owing to the influence of unfavorable factors, such as low brightness, low contrast, and noise, missed and wrong detections can occur.
WANG Feifan, CHEN Xi'ai, REN Weihong, GUAN Yu, HAN Zhi, TANG Yandong
doaj   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Robust contrast enhancement of noisy low-light images: denoising-enhancement-completion

open access: yes, 2015
A robust contrast enhancement algorithm for noisy low-light images, called the denoising-enhancement-completion (DEC), is proposed in this work. We observe that noise components in low-light images degrade the performance of the contrast enhancement ...
Jin-Hwan Kim   +7 more
core   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy